These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22296195)

  • 1. Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease.
    Roos CJ; Quax PH; Jukema JW
    Biomark Med; 2012 Feb; 6(1):35-52. PubMed ID: 22296195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
    Rana JS; Nieuwdorp M; Jukema JW; Kastelein JJ
    Diabetes Obes Metab; 2007 May; 9(3):218-32. PubMed ID: 17391148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic complications of obesity: inflated or inflamed?
    Chandalia M; Abate N
    J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and congestive heart failure.
    Hayden MR; Tyagi SC
    Med Sci Monit; 2003 Jul; 9(7):SR35-52. PubMed ID: 12883468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal obesity and metabolic syndrome.
    Després JP; Lemieux I
    Nature; 2006 Dec; 444(7121):881-7. PubMed ID: 17167477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular diabetology: clinical, metabolic and inflammatory facets. Preface.
    Fisman EZ; Tenenbaum A
    Adv Cardiol; 2008; 45():xi-xiii. PubMed ID: 18409234
    [No Abstract]   [Full Text] [Related]  

  • 7. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome and cardiovascular disease.
    Vitarius JA
    Mt Sinai J Med; 2005 Jul; 72(4):257-62. PubMed ID: 16021320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk?
    Lemieux I
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):795-7. PubMed ID: 15132969
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspective: nonalcoholic fatty liver disease and cardiovascular risk.
    Nestel PJ; Mensink RP
    Curr Opin Lipidol; 2013 Feb; 24(1):1-3. PubMed ID: 23298957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and the metabolic syndrome.
    Vega GL
    Minerva Endocrinol; 2004 Jun; 29(2):47-54. PubMed ID: 15257255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abdominal obesity and coronary heart disease. Pathophysiology and clinical significance].
    Hauner H
    Herz; 1995 Feb; 20(1):47-55. PubMed ID: 7713476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
    Koh KK; Han SH; Quon MJ
    J Am Coll Cardiol; 2005 Dec; 46(11):1978-85. PubMed ID: 16325028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
    Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
    Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing.
    Schroen B; Heymans S
    Cardiovasc Res; 2012 Mar; 93(4):605-13. PubMed ID: 21994347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing risk across the spectrum of patients with the metabolic syndrome.
    Rosenson RS
    Am J Cardiol; 2005 Aug; 96(4A):8E-10E. PubMed ID: 16098836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in Type 2 diabetes.
    Natarajan A; Marshall SM; Kesteven PJ; McComb JM; Rutter MK
    Diabet Med; 2011 Oct; 28(10):1201-5. PubMed ID: 21480978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasminogen activator inhibitor-1 (PAI-1), ischemic heart disease and diabetes mellitus].
    Olexa P; Olexová M
    Vnitr Lek; 2003 Mar; 49(3):222-6. PubMed ID: 12728597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.